maprotiline has been researched along with Schizophrenia in 10 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waehrens, J | 1 |
| Gerlach, J | 1 |
| Silver, H | 1 |
| Shmugliakov, N | 1 |
| Züchner, H | 1 |
| Bergener, M | 1 |
| Hesse, C | 1 |
| Hummel, F | 1 |
| Husser, J | 1 |
| Kern, U | 1 |
| Neller, K | 1 |
| Reiners, I | 1 |
| Strian, F | 1 |
| Albert, W | 1 |
| Klicpera, C | 1 |
| Pascalis, G | 1 |
| Maes, L | 1 |
| Krieger, D | 1 |
| Kielholz, P | 1 |
| Yamagami, S | 1 |
| Soejima, K | 1 |
| Svestka, J | 1 |
| Náhunek, K | 1 |
| Möller, HJ | 1 |
| Kissling, W | 1 |
| Bottermann, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Alterations in mRNA and Protein Expression in Human Peripheral Mononuclear Blood Cells (PMC) of Schizophrenia Patients Treated With Fluvoxamine Augmentation of Antipsychotics: Relationship to Clinical Symptoms and Cognitive Function[NCT00645580] | 15 participants (Anticipated) | Interventional | 2008-04-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for maprotiline and Schizophrenia
| Article | Year |
|---|---|
Antidepressant drugs in anergic schizophrenia. A double-blind cross-over study with maprotiline and placebo.
Topics: Adult; Aged; Anthracenes; Antidepressive Agents; Antipsychotic Agents; Clinical Trials as Topic; Dou | 1980 |
Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study.
Topics: Adult; Antidepressive Agents; Double-Blind Method; Female; Fluvoxamine; Humans; Male; Maprotiline; M | 1998 |
[Double blind study on maprotiline, an example of a multidimensional psychopharmacologic experiment (author's transl)].
Topics: Administration, Oral; Adult; Affective Disorders, Psychotic; Aged; Anthracenes; Clinical Trials as T | 1978 |
7 other studies available for maprotiline and Schizophrenia
| Article | Year |
|---|---|
[QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
Topics: Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain Damage, Chronic; | 2002 |
Antidepressive treatment and mood swing patterns in endogenous depression.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Bipolar Disorder; Clomipra | 1979 |
[Maprotiline in perfusions. An unexpected experience].
Topics: Adjustment Disorders; Anthracenes; Depression; Depressive Disorder, Major; Drug Evaluation; Humans; | 1977 |
Long-term therapy of affective disorders and schizophrenia.
Topics: Affective Symptoms; Antidepressive Agents, Tricyclic; Depression; Humans; Maprotiline; Physician-Pat | 1976 |
Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia.
Topics: Adult; Anthracenes; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Humans | 1989 |
Therapeutic results in acute phases of manic depressive and schizophrenic psychoses as possible predictors of the prophylactic effect.
Topics: Adult; Anthracenes; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Lithium; Male; Maprotili | 1989 |
The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Double-Blind Method; Endorphins; Female; Hu | 1986 |